
Company Number
10194513
Next Accounts
Sep 2025
Shareholders
guillem singla buxarrais
dimitris dimitris athanasiou
View AllGroup Structure
View All
Industry
Manufacture of other special-purpose machinery n.e.c.
Registered Address
9 shottery brook office park, timothys bridge road, stratford-upon-avon, CV37 9NR
Website
www.neurofenix.comPomanda estimates the enterprise value of NEUROFENIX LIMITED at £248.9k based on a Turnover of £499.2k and 0.5x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of NEUROFENIX LIMITED at £0 based on an EBITDA of £-1.2m and a 3.46x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of NEUROFENIX LIMITED at £8.9m based on Net Assets of £4.5m and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Neurofenix Limited is a live company located in stratford-upon-avon, CV37 9NR with a Companies House number of 10194513. It operates in the manufacture of other special-purpose machinery n.e.c. sector, SIC Code 28990. Founded in May 2016, it's largest shareholder is guillem singla buxarrais with a 11.4% stake. Neurofenix Limited is a young, micro sized company, Pomanda has estimated its turnover at £499.2k with declining growth in recent years.
Pomanda's financial health check has awarded Neurofenix Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £499.2k, make it smaller than the average company (£12.5m)
- Neurofenix Limited
£12.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -45%, show it is growing at a slower rate (5.3%)
- Neurofenix Limited
5.3% - Industry AVG
Production
with a gross margin of 30.7%, this company has a comparable cost of product (30.7%)
- Neurofenix Limited
30.7% - Industry AVG
Profitability
an operating margin of -246% make it less profitable than the average company (6.1%)
- Neurofenix Limited
6.1% - Industry AVG
Employees
with 7 employees, this is below the industry average (66)
7 - Neurofenix Limited
66 - Industry AVG
Pay Structure
on an average salary of £51.9k, the company has an equivalent pay structure (£51.9k)
- Neurofenix Limited
£51.9k - Industry AVG
Efficiency
resulting in sales per employee of £71.3k, this is less efficient (£187.2k)
- Neurofenix Limited
£187.2k - Industry AVG
Debtor Days
it gets paid by customers after 3 days, this is earlier than average (58 days)
- Neurofenix Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 65 days, this is slower than average (42 days)
- Neurofenix Limited
42 days - Industry AVG
Stock Days
it holds stock equivalent to 75 days, this is in line with average (88 days)
- Neurofenix Limited
88 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1123 weeks, this is more cash available to meet short term requirements (13 weeks)
1123 weeks - Neurofenix Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.5%, this is a lower level of debt than the average (48.5%)
2.5% - Neurofenix Limited
48.5% - Industry AVG
Neurofenix Limited's latest turnover from December 2023 is estimated at £499.2 thousand and the company has net assets of £4.5 million. According to their latest financial statements, Neurofenix Limited has 7 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | May 2019 | May 2018 | May 2017 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | 7 | 5 | 6 | 6 | 6 | 5 | 5 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | May 2019 | May 2018 | May 2017 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 33,043 | 56,123 | 25,206 | 7,550 | 5,557 | 6,453 | 4,988 | |
Intangible Assets | ||||||||
Investments & Other | 9 | 9 | 9 | |||||
Debtors (Due After 1 year) | ||||||||
Total Fixed Assets | 33,052 | 56,132 | 25,215 | 7,550 | 5,557 | 6,453 | 4,988 | |
Stock & work in progress | 71,552 | 40,759 | ||||||
Trade Debtors | 4,618 | 26,760 | 9,778 | 1,072,291 | 962,377 | 304,233 | 496,124 | 72,381 |
Group Debtors | 1,965,583 | 1,062,664 | 711,803 | |||||
Misc Debtors | 57,205 | 45,502 | 42,934 | 10,959 | 5,280 | 5,280 | ||
Cash | 2,528,513 | 4,437,778 | 497,608 | |||||
misc current assets | ||||||||
total current assets | 4,627,471 | 5,613,463 | 1,262,123 | 1,083,250 | 967,657 | 309,513 | 496,124 | 72,381 |
total assets | 4,660,523 | 5,669,595 | 1,287,338 | 1,090,800 | 973,214 | 315,966 | 501,112 | 72,381 |
Bank overdraft | ||||||||
Bank loan | ||||||||
Trade Creditors | 61,867 | 20,447 | 4,820 | 11,761 | 25,705 | 30,783 | 49,261 | 4,533 |
Group/Directors Accounts | ||||||||
other short term finances | ||||||||
hp & lease commitments | ||||||||
other current liabilities | 55,123 | 60,552 | 617,238 | |||||
total current liabilities | 116,990 | 80,999 | 622,058 | 11,761 | 25,705 | 30,783 | 49,261 | 4,533 |
loans | ||||||||
hp & lease commitments | ||||||||
Accruals and Deferred Income | 1,851 | 9,143 | 1 | 780 | ||||
other liabilities | ||||||||
provisions | ||||||||
total long term liabilities | 1,851 | 9,143 | 1 | 780 | ||||
total liabilities | 116,990 | 80,999 | 622,058 | 13,612 | 25,705 | 39,926 | 49,262 | 5,313 |
net assets | 4,543,533 | 5,588,596 | 665,280 | 1,077,188 | 947,509 | 276,040 | 451,850 | 67,068 |
total shareholders funds | 4,543,533 | 5,588,596 | 665,280 | 1,077,188 | 947,509 | 276,040 | 451,850 | 67,068 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | May 2019 | May 2018 | May 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 27,503 | 19,829 | ||||||
Amortisation | ||||||||
Tax | ||||||||
Stock | 30,793 | 40,759 | ||||||
Debtors | 892,480 | 370,411 | -318,735 | 115,593 | 471,533 | -186,611 | 423,743 | 72,381 |
Creditors | 41,420 | 15,627 | -6,941 | -13,944 | -23,556 | -18,478 | 44,728 | 4,533 |
Accruals and Deferred Income | -5,429 | -556,686 | 615,387 | 1,851 | -1 | 9,142 | -779 | 780 |
Deferred Taxes & Provisions | ||||||||
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 9 | |||||||
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | ||||||||
Group/Directors Accounts | ||||||||
Other Short Term Loans | ||||||||
Long term loans | ||||||||
Hire Purchase and Lease Commitments | ||||||||
other long term liabilities | ||||||||
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | -1,909,265 | 3,940,170 | 497,608 | |||||
overdraft | ||||||||
change in cash | -1,909,265 | 3,940,170 | 497,608 |
Perform a competitor analysis for neurofenix limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in CV37 area or any other competitors across 12 key performance metrics.
NEUROFENIX LIMITED group structure
Neurofenix Limited has no subsidiary companies.
Ultimate parent company
NEUROFENIX LIMITED
10194513
Neurofenix Limited currently has 4 directors. The longest serving directors include Mr Guillem Singla Buxarrais (May 2016) and Mr Dimitrios Athanasiou (Jul 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Guillem Singla Buxarrais | England | 32 years | May 2016 | - | Director |
Mr Dimitrios Athanasiou | England | 35 years | Jul 2016 | - | Director |
Ms Fatemeh Dehghan | 55 years | Dec 2019 | - | Director | |
Mr Peter Celano | England | 63 years | Dec 2023 | - | Director |
P&L
December 2023turnover
499.2k
+43%
operating profit
-1.2m
0%
gross margin
30.8%
+0.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
4.5m
-0.19%
total assets
4.7m
-0.18%
cash
2.5m
-0.43%
net assets
Total assets minus all liabilities
company number
10194513
Type
Private limited with Share Capital
industry
28990 - Manufacture of other special-purpose machinery n.e.c.
incorporation date
May 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
TAG ACCOUNTANTS GROUP LIMITED
auditor
-
address
9 shottery brook office park, timothys bridge road, stratford-upon-avon, CV37 9NR
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to neurofenix limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NEUROFENIX LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|